Garry Pairaudeau

2.9k total citations · 1 hit paper
35 papers, 1.9k citations indexed

About

Garry Pairaudeau is a scholar working on Molecular Biology, Organic Chemistry and Computational Theory and Mathematics. According to data from OpenAlex, Garry Pairaudeau has authored 35 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 15 papers in Organic Chemistry and 5 papers in Computational Theory and Mathematics. Recurrent topics in Garry Pairaudeau's work include Chemical Synthesis and Analysis (8 papers), Receptor Mechanisms and Signaling (8 papers) and Click Chemistry and Applications (5 papers). Garry Pairaudeau is often cited by papers focused on Chemical Synthesis and Analysis (8 papers), Receptor Mechanisms and Signaling (8 papers) and Click Chemistry and Applications (5 papers). Garry Pairaudeau collaborates with scholars based in United Kingdom, United States and Sweden. Garry Pairaudeau's co-authors include Michael J. Waring, Alex. M. Weir, Owen B. Wallace, Andrew R. Leach, John Arrowsmith, Stephen D. Pickett, Robert M. Owen, Ji‐Bo Wang, Paul D. Leeson and William D. Pennie and has published in prestigious journals such as Journal of the American Chemical Society, Journal of Biological Chemistry and Nature Reviews Drug Discovery.

In The Last Decade

Garry Pairaudeau

35 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An analysis of the attrition of drug candidates from four major pharmaceutical companies

2015 955 citations Michael J. Waring, John Arrowsmith et al. Nature Reviews Drug Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Garry Pairaudeau United Kingdom	17	759	582	436	247	143	35	1.9k
Owen B. Wallace United States	16	689 0.9×	403 0.7×	405 0.9×	156 0.6×	146 1.0×	27	1.6k
Rajesh Devraj United States	20	951 1.3×	746 1.3×	382 0.9×	157 0.6×	88 0.6×	35	1.9k
S. Barret Kalindjian United Kingdom	20	1.3k 1.7×	765 1.3×	657 1.5×	120 0.5×	173 1.2×	52	2.6k
Konstantin V. Balakin Russia	25	1.0k 1.4×	579 1.0×	671 1.5×	170 0.7×	75 0.5×	95	2.0k
Dearg S. Brown United Kingdom	18	660 0.9×	744 1.3×	278 0.6×	140 0.6×	174 1.2×	41	1.9k
Adam Yasgar United States	25	1.4k 1.9×	271 0.5×	540 1.2×	128 0.5×	144 1.0×	51	2.4k
Brian Springthorpe United Kingdom	5	879 1.2×	546 0.9×	589 1.4×	223 0.9×	41 0.3×	8	1.8k
Martyn Banks United States	17	1.0k 1.4×	241 0.4×	431 1.0×	93 0.4×	254 1.8×	37	1.7k
Alexander Hillisch Germany	28	1.4k 1.9×	458 0.8×	705 1.6×	212 0.9×	84 0.6×	57	2.8k
Ulrich Schopfer Switzerland	15	962 1.3×	496 0.9×	483 1.1×	85 0.3×	202 1.4×	34	1.8k

Countries citing papers authored by Garry Pairaudeau

Since Specialization

Citations

This map shows the geographic impact of Garry Pairaudeau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Garry Pairaudeau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Garry Pairaudeau more than expected).

Fields of papers citing papers by Garry Pairaudeau

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Garry Pairaudeau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Garry Pairaudeau. The network helps show where Garry Pairaudeau may publish in the future.

Co-authorship network of co-authors of Garry Pairaudeau

This figure shows the co-authorship network connecting the top 25 collaborators of Garry Pairaudeau. A scholar is included among the top collaborators of Garry Pairaudeau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Garry Pairaudeau. Garry Pairaudeau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Turner, S. J., et al.. (2024). Identification and Development of Cyclic Peptide Inhibitors of Hypoxia Inducible Factors 1 and 2 That Disrupt Hypoxia-Response Signaling in Cancer Cells. Journal of the American Chemical Society. 146(13). 8877–8886. 10 indexed citations

Madin, Andrew, et al.. (2022). Scope of on-DNA nucleophilic aromatic substitution on weakly-activated heterocyclic substrates for the synthesis of DNA-encoded libraries. Bioorganic & Medicinal Chemistry. 63. 116688–116688. 5 indexed citations

Hunter, James H., Marco Potowski, Andrew Madin, et al.. (2021). Functional Group Tolerance of a Micellar on-DNA Suzuki–Miyaura Cross-Coupling Reaction for DNA-Encoded Library Design. The Journal of Organic Chemistry. 86(24). 17930–17935. 12 indexed citations

Castillo, Francisco, et al.. (2018). A genetically selected cyclic peptide inhibitor of BCL6 homodimerization. Bioorganic & Medicinal Chemistry. 26(11). 3034–3038. 13 indexed citations

Fridén‐Saxin, Maria, Göran Dahl, Paul Wan, et al.. (2018). Inhibition of low-density lipoprotein receptor degradation with a cyclic peptide that disrupts the homodimerization of IDOL E3 ubiquitin ligase. Chemical Science. 9(27). 5957–5966. 19 indexed citations

Rees, Steve, Philip Gribbon, Karen Birmingham, William P. Janzen, & Garry Pairaudeau. (2015). Towards a hit for every target. Nature Reviews Drug Discovery. 15(1). 1–2. 21 indexed citations

Waring, Michael J., John Arrowsmith, Andrew R. Leach, et al.. (2015). An analysis of the attrition of drug candidates from four major pharmaceutical companies. Nature Reviews Drug Discovery. 14(7). 475–486. 955 indexed citations breakdown →

Forbes, Louisa V., Tove Sjögren, Françoise Auchère, et al.. (2013). Potent Reversible Inhibition of Myeloperoxidase by Aromatic Hydroxamates. Journal of Biological Chemistry. 288(51). 36636–36647. 88 indexed citations

Alcaraz, Lilian, Andrew Bailey, Elaine Cadogan, et al.. (2011). From libraries to candidate: The discovery of new ultra long-acting dibasic β2-adrenoceptor agonists. Bioorganic & Medicinal Chemistry Letters. 22(1). 689–695. 12 indexed citations

10.

Edman, K. A. P., Mark Furber, Paul Hemsley, et al.. (2011). The Discovery of MMP7 Inhibitors Exploiting a Novel Selectivity Trigger. ChemMedChem. 6(5). 769–773. 36 indexed citations

11.

Connolly, Stephen, Lilian Alcaraz, Andrew Bailey, et al.. (2011). Design-driven LO: The discovery of new ultra long acting dibasic β2-adrenoceptor agonists. Bioorganic & Medicinal Chemistry Letters. 21(15). 4612–4616. 13 indexed citations

12.

Young, Alan, David Nicholls, Stephen Connolly, et al.. (2011). The In Vivo Profile Of AZD3199: A Novel, Fast Acting B2-Agonist With A Long Duration Of Action. A1586–A1586. 4 indexed citations

13.

Johnstone, Craig, et al.. (2010). Creativity, innovation and lean sigma: a controversial combination?. Drug Discovery Today. 16(1-2). 50–57. 94 indexed citations

14.

Stocks, Michael J., et al.. (2009). A Practical Method for Targeted Library Design Balancing Lead‐like Properties with Diversity. ChemMedChem. 4(5). 800–808. 19 indexed citations

15.

Sanganee, Hitesh J., Andrew Baxter, Alastair Brown, et al.. (2009). Discovery of small molecule human C5a receptor antagonists. Bioorganic & Medicinal Chemistry Letters. 19(4). 1143–1147. 24 indexed citations

16.

Stocks, Michael J., et al.. (2007). Concise Synthesis of Novel 2,6-Diazaspiro[3.3]heptan-1-ones and Their Conversion into 2,6-Diazaspiro[3.3]heptanes. Synlett. 2007(16). 2587–2589. 6 indexed citations

17.

Caddick, Stephen, et al.. (2001). Stereoselective synthesis of polyfunctionalised hydroxylated cyclopentanes from dihydroxylated 2-cyclopentenone derivatives. Tetrahedron. 57(29). 6295–6303. 18 indexed citations

18.

Caddick, Stephen, et al.. (2000). Studies Toward the Synthesis of Natural and Unnatural Dienediynes. Part 2: A Practical Approach to Functionalised Cyclopentenones. Tetrahedron. 56(45). 8953–8958. 28 indexed citations

19.

Knight, Steven D., Ricardo Miledi, Nguyêñ Quôć Thǎńg, Larry E. Overman, & Garry Pairaudeau. (1995). The enantiomer of strychnine is a weak antagonist of the inhibitory glycine receptor. Bioorganic & Medicinal Chemistry Letters. 5(7). 749–752. 4 indexed citations

20.

Knight, Steven D., Larry E. Overman, & Garry Pairaudeau. (1995). Asymmetric Total Syntheses of (-)- and (+)-Strychnine and the Wieland-Gumlich Aldehyde. Journal of the American Chemical Society. 117(21). 5776–5788. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact